A detailed history of Hudson Bay Capital Management LP transactions in Liquidia Corp stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 600,000 shares of LQDA stock, worth $14.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
600,000
Previous 600,000 -0.0%
Holding current value
$14.5 Million
Previous $7.48 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$11.99 - $19.3 $7.06 Million - $11.4 Million
588,556 New
588,556 $7.33 Million
Q3 2020

Nov 12, 2020

SELL
$4.34 - $8.28 $154,013 - $293,832
-35,487 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$4.86 - $11.44 $172,466 - $405,971
35,487 New
35,487 $298,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.55B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.